A Single-arm, Interventional, Multi-center, Pilot Study to Evaluate the Efficacy of Oral Bisoprolol on Heart Rate Reduction in Chinese Chronic Heart Failure Patients With NYHA Class II - IV (Biso-CHF Study)

Trial Profile

A Single-arm, Interventional, Multi-center, Pilot Study to Evaluate the Efficacy of Oral Bisoprolol on Heart Rate Reduction in Chinese Chronic Heart Failure Patients With NYHA Class II - IV (Biso-CHF Study)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 31 May 2017

At a glance

  • Drugs Bisoprolol (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms Biso-CHF Study
  • Sponsors Merck KGaA
  • Most Recent Events

    • 23 May 2017 Planned End Date changed from 31 May 2019 to 31 Jan 2019.
    • 23 May 2017 Planned primary completion date changed from 28 Feb 2018 to 31 Jan 2019.
    • 28 Apr 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top